These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10370196)

  • 21. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
    Hao Z; Stowe EE; Ahluwalia G; Baker DC; Hebbler AK; Chisena C; Musser SM; Kelley JA; Perno CF; Johns DG
    Drug Metab Dispos; 1993; 21(4):738-44. PubMed ID: 7690699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of vesicular stomatitis virus RNA synthesis by 2',3'-dideoxycytidine 5'-triphosphate.
    Patton JT; Davis NL; Wertz GW
    J Gen Virol; 1983 Mar; 64 Pt 3():743-8. PubMed ID: 6298355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues.
    Magnani M; Rossi L; Casabianca A; Fraternale A; Schiavano G; Brandi G; Mannello F; Piedimonte G
    Adv Exp Med Biol; 1992; 326():239-45. PubMed ID: 1295313
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS).
    Serafini S; Fraternale A; Rossi L; Casabianca A; Antonelli A; Paoletti MF; Orlandi C; Pierigè F; Sfara C; Schiavano GF; Magnani M
    Antiviral Res; 2009 Feb; 81(2):93-102. PubMed ID: 18977391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP.
    Pelletier H; Sawaya MR; Kumar A; Wilson SH; Kraut J
    Science; 1994 Jun; 264(5167):1891-903. PubMed ID: 7516580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.
    Starnes MC; Cheng YC
    J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase.
    Feng JY; Anderson KS
    Biochemistry; 1999 Jan; 38(1):55-63. PubMed ID: 9890882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.
    Rossi L; Serafini S; Schiavano GF; Casabianca A; Vallanti G; Chiarantini L; Magnani M
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):915-20. PubMed ID: 10585881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intracellular diphosphonates on cells of the mononuclear phagocyte system: in vivo effects of liposome-encapsulated diphosphonates on different macrophage subpopulations in the spleen.
    van Rooijen N; Kors N
    Calcif Tissue Int; 1989 Sep; 45(3):153-6. PubMed ID: 2505906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro toxicity and metabolism of 2',3'-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity.
    Brandi G; Rossi L; Schiavano GF; Salvaggio L; Albano A; Magnani M
    Chem Biol Interact; 1991; 79(1):53-64. PubMed ID: 1647888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.
    Clouser CL; Holtz CM; Mullett M; Crankshaw DL; Briggs JE; O'Sullivan MG; Patterson SE; Mansky LM
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1942-8. PubMed ID: 22271861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS.
    Klinman DM; Krieg A; Conover J; Ussery MA; Black PL
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):101-6. PubMed ID: 1310603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
    Green KA; Noelle RJ; Durell BG; Green WR
    J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of teniposide to the mononuclear phagocytic system (MPS) by incorporation in liposomes and submicron lipid particles; an autoradiographic study in mice.
    Liliemark E; Sjöström B; Liliemark J; Peterson C; Kållberg N; Larsson BS
    Leuk Lymphoma; 1995 Jun; 18(1-2):113-8. PubMed ID: 8580812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of (alpha-P-borano)-2',3'-dideoxycytidine 5'-triphosphate into DNA by drug-resistant MMLV reverse transcriptase and Taq DNA polymerase.
    Dobrikov MI; Sergueeva ZA; Shaw BR
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1651-5. PubMed ID: 14565487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New drug combinations for the treatment of murine AIDS and macrophage protection.
    Fraternale A; Casabianca A; Tonelli A; Chiarantini L; Brandi G; Magnani M
    Eur J Clin Invest; 2001 Mar; 31(3):248-52. PubMed ID: 11264653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells.
    Aliño SF; Unda FJ; Iruarrizaga A; Alfaro J; Hilario E; Pérez-Yarza G; Bobadilla M; Lejarreta M
    Lab Invest; 1992 Jun; 66(6):671-9. PubMed ID: 1602737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.